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A nonacosapeptide (p-fragment) corresponding to the N-terminal sequence l-29 of human liver metallo- 
thionein II was synthesized by the fragment condensation method. The Cd-binding ability of the p-fragment 
was much stronger than that of cysteine as thionein and synthetic m-fragment corresponding to the C-terrni- 
nal sequence 30-61 of human liver metallothionein II. Both the a- and b-fragments bound preferentially 
to Cu ions rather than Cd ions. 
Human liver metallothionein II N-terminal nonacosapeptide Chemical synthesis Heavy metal-binding 
1. INTRODUCTION 
Metallothioneins are a class of low-M,, cysteine- 
rich metal-binding proteins. Otvos and Armitage 
[ 11 reported that rabbit metallothionein includes 
two separate metal clusters, one containing 4 Cd’+ 
(cluster A) and the other containing 3 (cluster B). 
Recently, Winge and Miklossy [2] isolated cluster 
A after proteolytic (subtilisin) digestion of rat MT, 
identified it as the C-terminal dotriacontapeptide 
(position 30-61) and designated it m-fragment. 
However, they failed to isolate the N-terminal 
polypeptide segment (cluster B, P-fragment) due to 
its degradation into a small peptide by subtilisin. 
Nielson and Winge [3] isolated Cu-binding N- 
terminal peptide after subtilisin digestion, which 
consisted of the N-terminal untriacontapeptide 
(position 1-31). They indicated that Cd ions 
bound to the a-domain preferentially and Cu ions 
Abbreviations: MT, metallothionein; n-BuOH, n- 
butanol; Z, benzyloxycarbonyl; Boc, tert- 
butyloxycarbonyl; Bzl, benzyl; MBzl, p-methoxybenzyl; 
DMF, N,N-dimethylformamide; AcOH, acetic acid; 
AcOEt, ethyl acetate 
to the &domain. This paper deals with the syn- 
thesis of a nonacosapeptide corresponding to the 
N-terminal sequence l-29 of human liver 
metallothionein II (hMT II) [4] and its heavy 
metal-binding properties. 
2. MATERIALS AND METHODS 
A nonacosapeptide was synthesized by the frag- 
ment condensation method. According to the 
route shown in fig. 1, 5 peptide fragments (l-5) 
were prepared stepwise or by fragment condensa- 
tion. Each peptide fragment was condensed suc- 
cessively by the azide method [5] to minimize 
racemization. The protected peptides were purified 
by reprecipitation from DMF/MeOH and/or col- 
umn chromatography on Sephadex LH-60. The 
final deprotection was performed by the HF 
method using thioanisole and m-cresol as 
scavengers [6]. The product obtained as the HF 
salt was converted to the acetate form by treatment 
with Amberlite IRA 45 (acetate form). After 
reduction with dithiothreitol and mercap- 
toethanol, the peptide was purified by gel filtration 
on Sephadex G-l 5 using 3% AcOH as an eluant. 
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(5) AC-Met-Asp-Pro-NHNH 
2 
LHF tm-cretol, thicmisolel 
Ac-Met-Asp-Pro-Asn-Cys-Ser-Cyr-Ala-Ala-Gly-Asp-Ser-Cys-Thr-Cyr- 
Ala-Cly-Ser-Cys-Lys-Cys-Lys-Glu-Cys-lys-Cyr-Thr-Ser-Cyr-OH (II 
Fig. 1. Synthetic route to N-terminal nonacosapeptide @- 
fragment) of human liver metallothionein II (I). 
[c# - 84.6’ (c = 0.1, 3% AcOH), TLC, Rr 0.41 
(n-BuOH : pyridine : AcOH : AcOEt = 4 : 1: 1: 2), 
0.80 (n-BuOH : pyridine : AcOH : Hz0 = 1: 1: 1: 1) 
(ninhydrin test, H2PtCWI test and nitroprusside 
test positive). Full details of the synthesis and 
characterization of this peptide will be published 
elsewhere (Y. Okada et al,, in preparation). 
The binding abilities of the peptide with heavy 
metals were studied by the ultraviolet (UV) absorp- 
tion method for Cd and the gel-filtration method 
of peptide-metal complex for Cd, Zn, and Cu as 
reported [7]. 
3. RESULTS AND DISCUSSION 
The free SH content of the synthetic 
nonacosapeptide (I) was 8,irlpeptide as calculated 
from the value for the SH content determined by 
the Ellman method [8] and the average recovery of 
amino acid. The amino acid ratios in acid 
hydrolysate were in good agreement with the ex- 
pected values as shown in table 1. This peptide was 
mixed with Zn2+ to form Zn-peptide complex, 
which was purified by gel fiitration on Sephadex 
G-75 as reported in [7]. The amino acid ratios in 
acid hydrolysate of the Zn-@fragment (I) complex 
so obtained are listed in table 1. Met residue was 
partially converted to Met sulfoxide during acid 
hydrolysis. From the value for the Zn content and 
the average recovery of amino acid, it was found 
that the Zn content of this complex was 
2.7lpeptide. Since Zn-peptide is easily replaced 
with Cd” f9] and Hg2+ [lo], the Zn-peptide can 
still act as a heavy metal detoxifying agent. 
The UV absorption of the peptide (I) and Cd- 
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Table 1 
Amino acid compositions of p-fragment (I), Zn- and 
Cu+-fragment complexes (residues/molecule) 
Residue ,&frag- Zn-p- cu-p- 
ment (I) fragment fragment 
Asp (3) 3.34 3.27 3.15 
Thr (2Y 1.87 1.71 1.76 
Ser (4)’ 3.43 3.85 3.67 
Glu (1) 1.00 0.80 1.01 
Pro (1) 1.10 0.90 0.88 
Gly (2) 2.30 2.10 2.00 
Ala (3) 3.03 3.02 3.07 
CYS (9) 8.50b __c _c 
Met (1) 0.80 0.52d _e 
LYS (3) 2.83 3.00 3.00 
a Values are from 20 h hydrolysate 
b Cys was determined after performic acid oxidation 
’ Cys was not determined 
d*e Met was partially and completely oxidized to form 
Met sulfoxide, respectively, during acid hydrolysis 
peptide (I) complex was quite similar to that of 
metal-free human MT and human MT, respective- 
ly [l 11. A broad absorption shoulder at 250 nm of 
the Cd-peptide is due to Cd-thiolate formation 
f 111. Since the extinction at 250 nm is proportional 
to the bound Cd content [11,12], the absorption 
can be used as an indicator of the content of bound 
metal ions. The Cd2’-binding activity of the syn- 
thetic p-fragment (I) was examined. Cd2+-mer- 
captide formation was measured by following the 
increase in absorbance at 250 nm, and the results 
are shown in fig.2 in comparison with those for 
thionein, synthetic a-fragment [131 and cysteine. 
The binding ability of the P-fragment was much 
stronger than that of cysteine as thionein and syn- 
thetic a-fragment. The &fragment (I) was 
saturated with Cd” at a concentration of 45-50 
pM, corresponding to 2.7-3.0 gatom/mol peptide. 
On the other hand, the synthetic a-fragment was 
saturated with Cd2” at a concentration of 50-55 
pM, corresponding to 3.6-3.9 gatom/moI peptide 
[13]. These values are in good agreement with the 
theoretically expected values. 
It has been reported that 0.1 ions bound 
preferentially to the P-domain and this order of 
cluster formation by Cu was opposite to that 
observed with Cd ions [3]. The &fragment (I) was 
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Fig.2. Binding ability of &fragment (I) with Cd2+. 
Peptide: 0.15 mM as SH, 3 ml in Tris-HCI (10 mM, pH 
7.0). (o--o) P-fragment (I), (0-0) a-fragment 1131, 
(s) rat thionein, (ti) cysteine. 
mixed with an excess amount of Cu2+ and Cd2+ at 
the same time, the molarities of which were equal 
to each other, and the resultant metal complex was 
separated by gel filtration on Sephadex G-10. The 
eluted material was examined by measuring the Cu 
and Cd contents by atomic absorption spec- 
trometry. The chromatographic pattern is shown 
in fig.3a. The Cu-P-fragment complex was eluted 
first, followed by blue-colored Cu2+ and then 
Cd’+. The amino acid ratios in acid hydrolysate of 
the Cu-P-fragment complex so obtained are listed 
in table 1. These ratios are in good agreement with 
the expected values except for Met, which was con- 
verted to Met sulfoxide presumably due to the 
presence of Cu2+ [14]. The data indicated that only 
Cu ions bound preferentially to the peptide (I) and 
not Cd’+. The values for the Cu content and the 
average recovery of amino acids or the SH content 
determined by the Ellman method suggested that 
the ratio of Cu to peptide was 3: 1. Nielson and 
Winge [3] reported that the P-domain bound to 6 
Cu ions and the a-domain to 5-6 Cu ions. The low 
value for the Cu content in our experiments might 
be due to Cu*+, which is known to catalyze oxida- 
tion of the thiol group to form a disulfide bond 
t141. 
The synthetic a-fragment [13] was also mixed 
with Cu2+ and Cd2+ and the resultant metal com- 
plex was isolated in the same manner as described 
above. The chromatographic pattern is shown in 
Tube No. Tube No. 
Fig.3. (a) Gel filtration of Cu-p-fragment complex on 
Sephadex G-10, (b) Cu-a-fragment complex. Aliquots 
of the elution fractions were examined by measuring the 
metal content by atomic absorption spectrometry. 
(o--o) Cu, (@-+I) Cd. 
fig.3b. The first peak corresponds to Cu-cy- 
fragment complex. The ratio of Cu to peptide was 
4: 1. This low value for the Cu content might be 
due to the same reason as described above. From 
these results, it appeared that the a-domain and ,8- 
domain could not discriminate between Cu2+ and 
Cd2’ when sufficient amounts of Cu and Cd were 
present at the same time. Since the affinity of Cu 
ions for the thiol group is stronger than that of Cd 
ions, both fragments bind to Cu ions. 
The MT of Neurospora crassa [ 151 is a 
25residue polypeptide, which contains 7 Cys 
residues, and is homologous to the &domain of 
mammalian MTs. Metal ions bind to N. crassa MT 
to form a single cluster [15]. The reason why fur- 
ther evolved MTs have two metal clusters is not yet 
understood. Detailed studies on the heavy metal- 
binding properties of the synthetic o- and ,8- 
fragments of MT should help to resolve the above 
question and clarify the intrinsic role of MT. 
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